MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia

NCT05464784 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Hypertriglyceridemia
Non-Alcoholic Fatty Liver Disease

Interventions

DRUG: MN-001
DRUG: MN-001 placebo

Sponsor

MediciNova